This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Second View: Prescriber check in with sleep medicine specialist on their impression of Quviviq (daridorexant) in treating Insomnia

Ticker(s): IDRSF

Who's the expert?

Shirish Amrutia, MD

  • specializes in COPD, asthma, pulmonary nodules and cancers, obstructive and central sleep apneas, complex sleep-disordered breathing, narcolepsy, restless leg syndrome, circadian rhythm disorders and insomnia.
  • 250 COPD patients annually approximately
  • Yes familiar with ENHANCE and Ensifentrine, eagerly waiting for FDA approval in near future

Interview Goal
.

Do you want answers to these questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.